| __timestamp | HUTCHMED (China) Limited | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26684000 | 44820000 |
| Thursday, January 1, 2015 | 29829000 | 82080000 |
| Friday, January 1, 2016 | 39578000 | 97130000 |
| Sunday, January 1, 2017 | 43277000 | 121271000 |
| Monday, January 1, 2018 | 48645000 | 153548000 |
| Tuesday, January 1, 2019 | 52934000 | 202541000 |
| Wednesday, January 1, 2020 | 61349000 | 245164000 |
| Friday, January 1, 2021 | 127125000 | 285773000 |
| Saturday, January 1, 2022 | 136106000 | 325998000 |
| Sunday, January 1, 2023 | 133175999 | 332540000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, PTC Therapeutics, Inc. and HUTCHMED (China) Limited have shown contrasting strategies in optimizing these costs. From 2014 to 2023, PTC Therapeutics saw a staggering 642% increase in SG&A expenses, peaking in 2023. In contrast, HUTCHMED's expenses grew by 399% over the same period.
PTC Therapeutics consistently outpaced HUTCHMED in SG&A spending, with 2023 figures showing PTC's expenses nearly 150% higher than HUTCHMED's. This trend suggests PTC's aggressive investment in administrative functions, possibly to support rapid growth. Meanwhile, HUTCHMED's more conservative approach may reflect a focus on cost efficiency. As these companies navigate the biotech landscape, their SG&A strategies will be pivotal in shaping their financial futures.
Operational Costs Compared: SG&A Analysis of Johnson & Johnson and HUTCHMED (China) Limited
Comparing SG&A Expenses: argenx SE vs HUTCHMED (China) Limited Trends and Insights
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Breaking Down SG&A Expenses: Insmed Incorporated vs PTC Therapeutics, Inc.
Alkermes plc or PTC Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: ADMA Biologics, Inc. vs HUTCHMED (China) Limited
Comparing SG&A Expenses: CymaBay Therapeutics, Inc. vs PTC Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Arrowhead Pharmaceuticals, Inc.
HUTCHMED (China) Limited and MannKind Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.